When was Ypsomed founded?

Ypsomed was founded in 2003 and raised its 1st funding round within a year of its incorporation.

Where is Ypsomed located?

Ypsomed is headquartered in Burgdorf, Switzerland. It is registered at 10/61/1-F KIRTI NAGAR INDUSTRIAL AREA, NEW DELHI, Delhi, India, 110015.

Who is the current CEO of Ypsomed?

Simon Michel of Ypsomed. They are also an angel investors in 1 startup.

How many employees does Ypsomed have?

As of Sep 30, 2026, the latest employee count at Ypsomed is 1373.

Is Ypsomed a funded company?

Ypsomed is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on 2003.

When was the latest funding round of Ypsomed?

Ypsomed's latest funding was a $***** Series A round on 2003, with participation from 1 investor.

What is the annual revenue of Ypsomed?

Annual revenue of Ypsomed is between £10M and £50M as on Mar 31, 2025

Where does Ypsomed rank among its competitors?

Ypsomed ranks 3rd amongst 65 active competitors, of which 13 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was CeQur, which secured $100M in Jun, 2026.

Who are the top competitors of Ypsomed?

Ypsomed's top competitors include Tandem Diabetes, Insulet and Kaleido. Among them, CeQur secured the most recent funding round in June, 2026.

Ypsomed - 2026 Company Profile, Team, Funding, Competitors & Financials

Ypsomed is an acquired company based in Burgdorf (Switzerland), founded in 2003. It operates as a Developer of self delivery injection systems and diabetes care systems. Ypsomed has raised $7.45M in funding. The company has 65 active competitors, including 13 funded and 17 that have exited. Its top competitors include companies like Tandem Diabetes, Insulet and Kaleido.

Company Details

Developer of self delivery injection systems and diabetes care systems. The company develops and manufactures injection systems for self-medication and supplier of products for diabetes care. The product portfolio includes Blood Glucose Monitoring Systems, Pen and safety pen needles, Infusion systems,

Website: www.ypsomed.com/en/
Email ID: *****@ypsomed.com
Phone Number: +41 **********
Registered Address: 10/61/1-F KIRTI NAGAR INDUSTRIAL AREA, NEW DELHI, Delhi, India, 110015

Key Metrics

Founded Year

2003

Location

Burgdorf, Switzerland

Stage

Acquired

Total Funding

$7.45M in 1 round

Latest Funding Round

Series A, 2003, $*****

Investors

BV Partners & 1 more

Ranked

3^rd among 65 active competitors

Annual Revenue

£10M - £50M as on Mar 31, 2025

Employee Count

1,373 as on Sep 30, 2026

Investment & Acquisitions

CeQur

Similar Companies

Insulet & 38 more

Exit Details

Acquired by TecMed Deutschland (Apr 24, 2025)

View Ypsomed's full profile

Ypsomed is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Ypsomed ApS CIN: 39888041 , Denmark, Active	Sep 23, 2018	-	-
YPSOMED LIMITED CIN: 7132723 , United Kingdom, Active	Jan 20, 2010	£10M - £50M (As on Mar 31, 2025)	39 (As on Mar 31, 2025)
YPSOMED INDIA PRIVATE LIMITED CIN: U74120DL2007PTC170003 , India, Active	Oct 31, 2007	₹10 - ₹50 Cr (As on Mar 31, 2025)	-

Ypsomed got acquired by TecMed Deutschland on Apr 24, 2025.

Click here to take a look at Ypsomed's acquisition in detail

Ypsomed has raised a total funding of $7.45M over 1 round. Its latest funding round was a Series A round on 2003 for $*****. 1 investor participated in its latest round. Ypsomed has 2 institutional investors.

Here is the list of recent funding rounds of Ypsomed:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2003	4113	Series A	4872	5150	9718	3031

Access funding benchmarks and valuations. Sign up today!

View details of Ypsomed's funding rounds and investors

Ypsomed's employee count trend

Ypsomed has 1,373 employees as of Sep 26. Here is Ypsomed's employee count trend over the years:

Uncover Ypsomed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ypsomed include Tandem Diabetes, Insulet and Kaleido. Here is the list of Top 10 competitors of Ypsomed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tandem Diabetes 2008, San Diego (United States), Public	Developer of devices for continuous glucose monitoring and manual insulin delivery	$101M	Gynther Capital, Domain Associates & 5 others	77/100
2nd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	74/100
3rd	Ypsomed 2003, Burgdorf (Switzerland), Acquired	Developer of self delivery injection systems and diabetes care systems	$7.45M	BV Partners, BV Group	65/100
4th	Kaleido 2013, Utrecht (Netherlands), Series D	Developer of insulin therapy for treating diabetes	$183M	Life Sciences Partners, Innovation Industries ... & 10 others	64/100
5th	CeQur 2008, Horw (Switzerland), Series E	Developer of wearable insulin delivery patch	$492M	Endeavour Vision, Schroders & 7 others	59/100
6th	Microtech Medical 2011, Hangzhou (China), Public	Medical devices developer for diabetes care	$88.2M	Tencent, IDG Capital & 9 others	58/100
7th	Sigrid Therapeutics 2014, Stockholm (Sweden), Series C	Developer of therapies to treat metabolic and chronic lifestyle diseases	$27M	Irrus Investments, Joyance Partners & 9 others	57/100
8th	Omnipod 1999, Acton (United States), Unfunded	Provider of smart wearable disposable pod provides insulin delivery	-	-	54/100
9th	Embecta 2022, Parsippany (United States), Public	Manufacturer of insulin delivery solutions, including pen needles and insulin syringes	-	-	53/100
10th	Modular Medical 2017, San Diego (United States), Series A	Developer of insulin pump for insulin delivery	$5.28M	-	52/100